早期卵巢癌术中囊肿破裂:子宫内膜异位症相关亚型分析
回顾性单中心队列研究纳入239例疑似FIGO I期上皮性卵巢癌患者,按病理分为子宫内膜异位症相关卵巢癌(ECOC,75例)、子宫内膜异位症偶发卵巢癌(EIOC,46例)和无子宫内膜异位症卵巢癌(NEOC,118例)。术中囊肿破裂在ECOC(20%)中显著高于EIOC(13%)和NEOC(5%)(p=.006),但破裂未与更差的无进展生存或腹膜复发风险相关;ECOC独立与改善的无进展生存和较低腹膜复发风险相关。
要点
- ECOC术中囊肿破裂率20%,显著高于EIOC的13%和NEOC的5%(p=.006)。
- 术中囊肿破裂未与更差的无进展生存或腹膜复发风险相关。
- ECOC独立与改善的无进展生存和较低腹膜复发风险相关。
核心结论
- 在疑似早期上皮性卵巢癌中,术中囊肿破裂在ECOC中更常见,但未对肿瘤学结局产生不良影响。
- 肿瘤生物学而非单纯手术事件(囊肿破裂)似乎是疾病行为的首要驱动因素。
研究设计与样本
- 回顾性单中心队列研究,纳入239例疑似FIGO I期上皮性卵巢癌接受初次手术治疗的患者。
- 按病理分为ECOC(n=75)、EIOC(n=46)和NEOC(n=118)三组。
主要发现
- 术中囊肿破裂发生率:ECOC 20%,EIOC 13%,NEOC 5%(p=.006),ECOC是唯一独立与破裂风险相关的因素。
- 囊肿破裂未与更差的无进展生存或增加的腹膜复发风险相关。
- ECOC独立与改善的无进展生存和较低的腹膜复发风险相关。
- 微创手术方式与更高的疾病进展风险相关,但需谨慎解读,可能反映残余混杂、选择偏倚、肿瘤生物学或其他未测量因素。
关键数值与推荐
- 术中囊肿破裂发生率ECOC 20%、EIOC 13%、NEOC 5%,组间比较p=.006。
- ECOC是唯一独立与囊肿破裂风险相关的因素。
- ECOC独立与改善的无进展生存和较低腹膜复发风险相关。
- 微创手术方式与更高疾病进展风险相关(需谨慎解读)。
临床怎么用
- 对于疑似早期上皮性卵巢癌,尤其ECOC亚型,术中囊肿破裂风险较高,但不应因担心破裂而改变必要的手术决策。
- 手术决策应更多基于肿瘤生物学特征,而非仅关注囊肿破裂这一手术事件。
局限性
- 回顾性单中心设计。
- 微创手术与疾病进展风险相关的发现可能存在残余混杂、选择偏倚、肿瘤生物学或其他未测量因素。
- 总生存分析仅为探索性目的。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To evaluate the incidence and oncologic impact of intraoperative cyst rupture in apparent early-stage epithelial ovarian cancer, with a focus on the role of endometriosis in modulating surgical risk and disease behavior. DESIGN: Retrospective single-center cohort study. SETTING: Tertiary referral teaching hospital. PARTICIPANTS: A total of 239 patients with apparent FIGO stage I epithelial ovarian cancer who underwent primary surgical treatment. Patients were stratified into 3 groups according to histopathologic findings: endometriosis-correlated ovarian cancer (ECOC, n = 75), endometriosis-incidental ovarian cancer (EIOC, n = 46), and ovarian cancer without endometriosis (NEOC, n = 118). INTERVENTIONS: Occurrence of intraoperative cyst rupture was recorded for all patients. MEASUREMENTS AND MAIN RESULTS: The primary outcomes were the incidence of intraoperative cyst rupture, progression-free survival, and peritoneal recurrence, evaluated using logistic and Cox regression models, whereas analyses of overall survival were conducted for exploratory purposes only. Intraoperative cyst rupture occurred significantly more often in ECOC (20%) than in EIOC (13%) and NEOC (5%) (p = .006), with ECOC being the only factor independently associated with rupture risk. Despite this higher rupture rate, cyst rupture was not associated with worse progression-free survival or increased risk of peritoneal relapse. Conversely, ECOC was independently associated with improved progression-free survival and a lower risk of peritoneal recurrence. A minimally invasive surgical approach was associated with a higher risk of disease progression, although this finding should be interpreted with caution, as it may reflect residual confounding, selection bias, tumor biology, or other unmeasured factors. CONCLUSION: In apparent early-stage epithelial ovarian cancer, intraoperative cyst rupture occurs more frequently in ECOC but does not adversely affect oncologic outcomes. Tumor biology, rather than the surgical event of cyst rupture alone, appears to be the primary driver of disease behavior. These findings support a more biology-informed approach to surgical decision-making in early-stage epithelial ovarian cancer.
引用
- Mantovani G, Mezzapesa F, Scarpelli E, et al. Intraoperative Cyst Rupture in Early-Stage Ovarian Cancer: An Analysis of Endometriosis-Associated Subtypes. J Minim Invasive Gynecol. 2026. PMID: 42826790. doi:10.1016/j.jmig.2026.09.470
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。